Global Vitamin Deficiency Treatment

Vitamin Deficiency Treatment Comprehensive Study by Type (Multivitamin Deficiency Treatment, Single Vitamin Deficiency Treatment), End Users (Adults, Kids), Route of Administration (Oral, Parenteral), Product Type (Vitamin A Supplements, Vitamin B Supplements, Vitamin C Supplements, Vitamin D Supplements, Other) Players and Region - Global Market Outlook to 2026

Vitamin Deficiency Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Vitamin Deficiency Treatment Market Overview:
Vitamin Deficiency is a lack of healthy red blood cells caused when you have lower than normal amounts of certain vitamins. It is the condition of a long-term lack of a vitamin that occurs if a person is not eating enough foods containing vitamins or his/her body has trouble absorbing or processing these vitamins. As per sources, in the United States, about 42% of people may be vitamin D deficient. This number rises to 74% in older adults and 82% in people with dark skin since their skin produces less vitamin D in response to sunlight. Moreover, iron deficiency is one of the most common nutrient deficiencies in the world, affecting more than 25% of people worldwide. According to WHO, vitamin A deficiency is the leading cause of preventable blindness among children. The rising demand for vitamin supplements is expected to drive market growth in upcoming years. Some of the players profiled in the study are Merck & Co., Inc. (Germany), Pfizer, Inc. (United States), Cipla, Inc. (India), F. Hoffmann-La Roche (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pharmavite (United States), BASF SE (Germany), Koninkljike DSM N.V (The Netherlands), Novartis AG (Switzerland), GlaxoSmithKline plc (Germany) and Nestlé S.A. (Switzerland).

On the basis of geography, the market of Vitamin Deficiency Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Adults will boost the Vitamin Deficiency Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Vitamin Deficiency Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product Type, the sub-segment i.e. Vitamin A Supplements will boost the Vitamin Deficiency Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Rising Number Of Vitamin D Deficiencies
  • Imbalanced Diet In The Underdeveloped Countries Has Increased Vitamin Deficiencies Among People

Influencing Trend
  • Rising Health Awareness

Restraints
  • Lack Of Availability For Treatments In Developing Nations

Opportunities
  • The Government Initiatives And Campaign For Awareness
  • Expenditure On R&D For Vitamin Deficiency Treatment

Challenges
  • Increasing Price Of Treatments




The global vitamin deficiency treatment market is fragmented and it has been observed that most of the companies are upgrading or introducing innovative products. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation, and sourcing strategies to enhance their market share.

Target Audience:
New Entrants/Investors, Analysts and Strategic Business Planners, Vitamin Deficiency Treatment Providers, Vitamin Supplement Manufacturers, Vitamin Supplement Suppliers and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Vitamin Deficiency Treatment market on the basis of product [Multivitamin Deficiency Treatment and Single Vitamin Deficiency Treatment] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Vitamin Deficiency Treatment market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Vitamin Deficiency Treatment industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Sandoz (Germany), Mankind Pharma (India), Dabur International (India) and Nature's Bounty (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Vitamin Deficiency Treatment market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Multivitamin Deficiency Treatment
  • Single Vitamin Deficiency Treatment
By End Users
  • Adults
  • Kids

By Route of Administration
  • Oral
  • Parenteral

By Product Type
  • Vitamin A Supplements
  • Vitamin B Supplements
  • Vitamin C Supplements
  • Vitamin D Supplements
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number Of Vitamin D Deficiencies
      • 3.2.2. Imbalanced Diet In The Underdeveloped Countries Has Increased Vitamin Deficiencies Among People
    • 3.3. Market Challenges
      • 3.3.1. Increasing Price Of Treatments
    • 3.4. Market Trends
      • 3.4.1. Rising Health Awareness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vitamin Deficiency Treatment, by Type, End Users, Route of Administration, Product Type and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Vitamin Deficiency Treatment (Value)
      • 5.2.1. Global Vitamin Deficiency Treatment by: Type (Value)
        • 5.2.1.1. Multivitamin Deficiency Treatment
        • 5.2.1.2. Single Vitamin Deficiency Treatment
      • 5.2.2. Global Vitamin Deficiency Treatment by: End Users (Value)
        • 5.2.2.1. Adults
        • 5.2.2.2. Kids
      • 5.2.3. Global Vitamin Deficiency Treatment by: Route of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Parenteral
      • 5.2.4. Global Vitamin Deficiency Treatment by: Type (Value)
        • 5.2.4.1. Multivitamin Deficiency Treatment
        • 5.2.4.2. Single Vitamin Deficiency Treatment
      • 5.2.5. Global Vitamin Deficiency Treatment by: Product Type (Value)
        • 5.2.5.1. Vitamin A Supplements
        • 5.2.5.2. Vitamin B Supplements
        • 5.2.5.3. Vitamin C Supplements
        • 5.2.5.4. Vitamin D Supplements
        • 5.2.5.5. Other
      • 5.2.6. Global Vitamin Deficiency Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Vitamin Deficiency Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co., Inc. (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cipla, Inc. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. F. Hoffmann-La Roche (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pharmavite (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BASF SE (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Koninkljike DSM N.V (The Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GlaxoSmithKline plc (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Nestlé S.A. (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Vitamin Deficiency Treatment Sale, by Type, End Users, Route of Administration, Product Type and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Vitamin Deficiency Treatment (Value)
      • 7.2.1. Global Vitamin Deficiency Treatment by: Type (Value)
        • 7.2.1.1. Multivitamin Deficiency Treatment
        • 7.2.1.2. Single Vitamin Deficiency Treatment
      • 7.2.2. Global Vitamin Deficiency Treatment by: End Users (Value)
        • 7.2.2.1. Adults
        • 7.2.2.2. Kids
      • 7.2.3. Global Vitamin Deficiency Treatment by: Route of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Parenteral
      • 7.2.4. Global Vitamin Deficiency Treatment by: Type (Value)
        • 7.2.4.1. Multivitamin Deficiency Treatment
        • 7.2.4.2. Single Vitamin Deficiency Treatment
      • 7.2.5. Global Vitamin Deficiency Treatment by: Product Type (Value)
        • 7.2.5.1. Vitamin A Supplements
        • 7.2.5.2. Vitamin B Supplements
        • 7.2.5.3. Vitamin C Supplements
        • 7.2.5.4. Vitamin D Supplements
        • 7.2.5.5. Other
      • 7.2.6. Global Vitamin Deficiency Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vitamin Deficiency Treatment: by Type(USD Million)
  • Table 2. Vitamin Deficiency Treatment Multivitamin Deficiency Treatment , by Region USD Million (2015-2020)
  • Table 3. Vitamin Deficiency Treatment Single Vitamin Deficiency Treatment , by Region USD Million (2015-2020)
  • Table 4. Vitamin Deficiency Treatment: by End Users(USD Million)
  • Table 5. Vitamin Deficiency Treatment Adults , by Region USD Million (2015-2020)
  • Table 6. Vitamin Deficiency Treatment Kids , by Region USD Million (2015-2020)
  • Table 7. Vitamin Deficiency Treatment: by Route of Administration(USD Million)
  • Table 8. Vitamin Deficiency Treatment Oral , by Region USD Million (2015-2020)
  • Table 9. Vitamin Deficiency Treatment Parenteral , by Region USD Million (2015-2020)
  • Table 10. Vitamin Deficiency Treatment: by Type(USD Million)
  • Table 11. Vitamin Deficiency Treatment Multivitamin Deficiency Treatment , by Region USD Million (2015-2020)
  • Table 12. Vitamin Deficiency Treatment Single Vitamin Deficiency Treatment , by Region USD Million (2015-2020)
  • Table 13. Vitamin Deficiency Treatment: by Product Type(USD Million)
  • Table 14. Vitamin Deficiency Treatment Vitamin A Supplements , by Region USD Million (2015-2020)
  • Table 15. Vitamin Deficiency Treatment Vitamin B Supplements , by Region USD Million (2015-2020)
  • Table 16. Vitamin Deficiency Treatment Vitamin C Supplements , by Region USD Million (2015-2020)
  • Table 17. Vitamin Deficiency Treatment Vitamin D Supplements , by Region USD Million (2015-2020)
  • Table 18. Vitamin Deficiency Treatment Other , by Region USD Million (2015-2020)
  • Table 19. South America Vitamin Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 20. South America Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 21. South America Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 22. South America Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 23. South America Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 24. Brazil Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 25. Brazil Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 26. Brazil Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 27. Brazil Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 28. Argentina Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 29. Argentina Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 30. Argentina Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 31. Argentina Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 32. Rest of South America Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 34. Rest of South America Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 35. Rest of South America Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 36. Asia Pacific Vitamin Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 39. Asia Pacific Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 40. Asia Pacific Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 41. China Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 42. China Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 43. China Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 44. China Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 45. Japan Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 46. Japan Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 47. Japan Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 48. Japan Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 49. India Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 50. India Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 51. India Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 52. India Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 53. South Korea Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 54. South Korea Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 55. South Korea Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 56. South Korea Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 57. Taiwan Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 58. Taiwan Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 59. Taiwan Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 60. Taiwan Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 61. Australia Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 62. Australia Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 63. Australia Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 64. Australia Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 69. Europe Vitamin Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 70. Europe Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 71. Europe Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 72. Europe Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 73. Europe Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 74. Germany Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 75. Germany Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 76. Germany Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 77. Germany Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 78. France Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 79. France Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 80. France Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 81. France Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 82. Italy Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 83. Italy Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 84. Italy Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 85. Italy Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 86. United Kingdom Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 88. United Kingdom Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 89. United Kingdom Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 90. Netherlands Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 91. Netherlands Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 92. Netherlands Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 93. Netherlands Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 94. Rest of Europe Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 96. Rest of Europe Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 97. Rest of Europe Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 98. MEA Vitamin Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 99. MEA Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 100. MEA Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 101. MEA Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 102. MEA Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 103. Middle East Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 104. Middle East Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 105. Middle East Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 106. Middle East Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 107. Africa Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 108. Africa Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 109. Africa Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 110. Africa Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 111. North America Vitamin Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 112. North America Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 113. North America Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 114. North America Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 115. North America Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 116. United States Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 117. United States Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 118. United States Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 119. United States Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 120. Canada Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 121. Canada Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 122. Canada Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 123. Canada Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 124. Mexico Vitamin Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 125. Mexico Vitamin Deficiency Treatment, by End Users USD Million (2015-2020)
  • Table 126. Mexico Vitamin Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 127. Mexico Vitamin Deficiency Treatment, by Product Type USD Million (2015-2020)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Vitamin Deficiency Treatment: by Type(USD Million)
  • Table 140. Vitamin Deficiency Treatment Multivitamin Deficiency Treatment , by Region USD Million (2021-2026)
  • Table 141. Vitamin Deficiency Treatment Single Vitamin Deficiency Treatment , by Region USD Million (2021-2026)
  • Table 142. Vitamin Deficiency Treatment: by End Users(USD Million)
  • Table 143. Vitamin Deficiency Treatment Adults , by Region USD Million (2021-2026)
  • Table 144. Vitamin Deficiency Treatment Kids , by Region USD Million (2021-2026)
  • Table 145. Vitamin Deficiency Treatment: by Route of Administration(USD Million)
  • Table 146. Vitamin Deficiency Treatment Oral , by Region USD Million (2021-2026)
  • Table 147. Vitamin Deficiency Treatment Parenteral , by Region USD Million (2021-2026)
  • Table 148. Vitamin Deficiency Treatment: by Type(USD Million)
  • Table 149. Vitamin Deficiency Treatment Multivitamin Deficiency Treatment , by Region USD Million (2021-2026)
  • Table 150. Vitamin Deficiency Treatment Single Vitamin Deficiency Treatment , by Region USD Million (2021-2026)
  • Table 151. Vitamin Deficiency Treatment: by Product Type(USD Million)
  • Table 152. Vitamin Deficiency Treatment Vitamin A Supplements , by Region USD Million (2021-2026)
  • Table 153. Vitamin Deficiency Treatment Vitamin B Supplements , by Region USD Million (2021-2026)
  • Table 154. Vitamin Deficiency Treatment Vitamin C Supplements , by Region USD Million (2021-2026)
  • Table 155. Vitamin Deficiency Treatment Vitamin D Supplements , by Region USD Million (2021-2026)
  • Table 156. Vitamin Deficiency Treatment Other , by Region USD Million (2021-2026)
  • Table 157. South America Vitamin Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 158. South America Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 159. South America Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 160. South America Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 161. South America Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 162. Brazil Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 163. Brazil Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 164. Brazil Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 165. Brazil Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 166. Argentina Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 167. Argentina Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 168. Argentina Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 169. Argentina Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 170. Rest of South America Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 171. Rest of South America Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 172. Rest of South America Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 173. Rest of South America Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 174. Asia Pacific Vitamin Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 175. Asia Pacific Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 176. Asia Pacific Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 177. Asia Pacific Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 178. Asia Pacific Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 179. China Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 180. China Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 181. China Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 182. China Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 183. Japan Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 184. Japan Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 185. Japan Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 186. Japan Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 187. India Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 188. India Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 189. India Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 190. India Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 191. South Korea Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 192. South Korea Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 193. South Korea Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 194. South Korea Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 195. Taiwan Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 196. Taiwan Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 197. Taiwan Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 198. Taiwan Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 199. Australia Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 200. Australia Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 201. Australia Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 202. Australia Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 207. Europe Vitamin Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 208. Europe Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 209. Europe Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 210. Europe Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 211. Europe Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 212. Germany Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 213. Germany Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 214. Germany Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 215. Germany Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 216. France Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 217. France Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 218. France Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 219. France Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 220. Italy Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 221. Italy Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 222. Italy Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 223. Italy Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 224. United Kingdom Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 225. United Kingdom Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 226. United Kingdom Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 227. United Kingdom Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 228. Netherlands Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 229. Netherlands Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 230. Netherlands Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 231. Netherlands Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 232. Rest of Europe Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 233. Rest of Europe Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 234. Rest of Europe Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 235. Rest of Europe Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 236. MEA Vitamin Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 237. MEA Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 238. MEA Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 239. MEA Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 240. MEA Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 241. Middle East Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 242. Middle East Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 243. Middle East Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 244. Middle East Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 245. Africa Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 246. Africa Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 247. Africa Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 248. Africa Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 249. North America Vitamin Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 250. North America Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 251. North America Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 252. North America Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 253. North America Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 254. United States Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 255. United States Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 256. United States Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 257. United States Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 258. Canada Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 259. Canada Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 260. Canada Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 261. Canada Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 262. Mexico Vitamin Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 263. Mexico Vitamin Deficiency Treatment, by End Users USD Million (2021-2026)
  • Table 264. Mexico Vitamin Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 265. Mexico Vitamin Deficiency Treatment, by Product Type USD Million (2021-2026)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vitamin Deficiency Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Vitamin Deficiency Treatment: by End Users USD Million (2015-2020)
  • Figure 6. Global Vitamin Deficiency Treatment: by Route of Administration USD Million (2015-2020)
  • Figure 7. Global Vitamin Deficiency Treatment: by Type USD Million (2015-2020)
  • Figure 8. Global Vitamin Deficiency Treatment: by Product Type USD Million (2015-2020)
  • Figure 9. South America Vitamin Deficiency Treatment Share (%), by Country
  • Figure 10. Asia Pacific Vitamin Deficiency Treatment Share (%), by Country
  • Figure 11. Europe Vitamin Deficiency Treatment Share (%), by Country
  • Figure 12. MEA Vitamin Deficiency Treatment Share (%), by Country
  • Figure 13. North America Vitamin Deficiency Treatment Share (%), by Country
  • Figure 14. Global Vitamin Deficiency Treatment share by Players 2020 (%)
  • Figure 15. Global Vitamin Deficiency Treatment share by Players (Top 3) 2020(%)
  • Figure 16. Global Vitamin Deficiency Treatment share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Merck & Co., Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Merck & Co., Inc. (Germany) Revenue: by Geography 2020
  • Figure 20. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Cipla, Inc. (India) Revenue, Net Income and Gross profit
  • Figure 23. Cipla, Inc. (India) Revenue: by Geography 2020
  • Figure 24. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2020
  • Figure 26. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 27. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2020
  • Figure 28. Pharmavite (United States) Revenue, Net Income and Gross profit
  • Figure 29. Pharmavite (United States) Revenue: by Geography 2020
  • Figure 30. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 31. BASF SE (Germany) Revenue: by Geography 2020
  • Figure 32. Koninkljike DSM N.V (The Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Koninkljike DSM N.V (The Netherlands) Revenue: by Geography 2020
  • Figure 34. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 36. GlaxoSmithKline plc (Germany) Revenue, Net Income and Gross profit
  • Figure 37. GlaxoSmithKline plc (Germany) Revenue: by Geography 2020
  • Figure 38. Nestlé S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 39. Nestlé S.A. (Switzerland) Revenue: by Geography 2020
  • Figure 40. Global Vitamin Deficiency Treatment: by Type USD Million (2021-2026)
  • Figure 41. Global Vitamin Deficiency Treatment: by End Users USD Million (2021-2026)
  • Figure 42. Global Vitamin Deficiency Treatment: by Route of Administration USD Million (2021-2026)
  • Figure 43. Global Vitamin Deficiency Treatment: by Type USD Million (2021-2026)
  • Figure 44. Global Vitamin Deficiency Treatment: by Product Type USD Million (2021-2026)
  • Figure 45. South America Vitamin Deficiency Treatment Share (%), by Country
  • Figure 46. Asia Pacific Vitamin Deficiency Treatment Share (%), by Country
  • Figure 47. Europe Vitamin Deficiency Treatment Share (%), by Country
  • Figure 48. MEA Vitamin Deficiency Treatment Share (%), by Country
  • Figure 49. North America Vitamin Deficiency Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck & Co., Inc. (Germany)
  • Pfizer, Inc. (United States)
  • Cipla, Inc. (India)
  • F. Hoffmann-La Roche (Switzerland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Pharmavite (United States)
  • BASF SE (Germany)
  • Koninkljike DSM N.V (The Netherlands)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline plc (Germany)
  • Nestlé S.A. (Switzerland)
Additional players considered in the study are as follows:
Sandoz (Germany) , Mankind Pharma (India) , Dabur International (India) , Nature's Bounty (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 239 Pages 86 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Vitamin Deficiency Treatment Quantitative research analysis
Global Vitamin Deficiency Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Vitamin Deficiency Treatment Report?

Have a Query? Click Here

Other Related Reports

Bronchitis Treatment Comprehensive Study by Type (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Drugs Class (Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Other), ...
$ 3450
Preterm Labor Treatment Comprehensive Study by Type (Devices, Cervical Cerclage, Vaginal Pessaries, Drug), Application (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes, Pharmacy), Distributi...
$ 3750
Parkinson's Disease Treatment Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), Patient Care Setting (Hospitals, Clinics), Drug Class (Carbido...
$ 3650
Mantle Cell Lymphoma Treatment Comprehensive Study by Type (Acalabrutinib, JCAR-017, JNJ-64052781, Acalisib, IGN-002, IMGN-529, AFM-11, Others), Application (Hospital, Clinic, Others), Route of Admin...
$ 3650
Non-alcoholic Steatohepatitis Comprehensive Study by Type (Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, Others), Application (Hypertension, Heart Disease, High Blood Lipid, Diabetes, Obesity), En...
$ 3450
Ophthalmology Drugs Comprehensive Study by Type (Lucentis (Ranibizumab), Eylea (Aflibercept), Avastin (Bevacizumab), Restasis (Cyclosporine), Alphagan (Brimonidine Tartrate), Lumigan (Bimatoprost), X...
$ 3750